India’s first largest biotechnology stakeholders conglomerate, – the Global Bio-India (GBI) Summit, 2019 was held in New Delhi
India’s Biotech sector representation at a single forum. Harness opportunities, identify challenges & welcome stakeholders to explore partners for inclusive growth & transform lives. Other objectives are;
- Bio – Partnering, Policy Discussions, CEO’s plans for India & asks from India
- Showcase and identify key biotechnological innovations, products, services, technologies from national and international companies, start-ups and research institutes
- Identify funding and collaboration opportunities for research and development
- Explore licensing options for existing products
- Attracting major contract projects from international companies as well as major global venture funding into India
- Create platforms for new idea evaluation and investments
- Opportunity for Indian State Governments to attract foreign investment into their respective States
- Discuss key trends and policy interventions across all sub-sectors including bio-pharma, bio-agriculture, bio-industrial, bio-energy, bio-manufacturing, bio-services etc. and establish takeaways
- Connect Indian Biotech ecosystem with international ecosystem
- Learning platform experience of other successful geographies and companies
- Facilitate interactions of research institutions with the industry
- The three-day event was organized by the Department of Biotechnology (DBT), Ministry of Science & Technology, Government of India along with its Public Sector Undertaking, Biotechnology Industry Research Assistance Council (BIRAC).
- The associated partners for this event were Confederation of Indian Industry (CII), Association of Biotechnology Led Enterprises (ABLE) and Invest India.
- Biotechnology is recognized as the sunrise sector- a key driver for contributing to India’s USD 5 Trillion economy target by 2025.
- Significance: The Summit provided an opportunity to showcase the potential of India’s biotech sector to the international community, identify, create opportunities and deliberate on the key challenges in the areas of Bio-pharma, Bio-Agri, Bio-Industrial, Bio-Energy and Bio-Services and allied sectors